Genomic analysis of fibrolamellar hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Genomic analysis of fibrolamellar hepatocellular carcinoma.

Genomic analysis of fibrolamellar hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34673400

about

Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular Carcinoma Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology Structural insights into mis-regulation of protein kinase A in human tumors.Somatic microsatellite variability as a predictive marker for colorectal cancer and liver cancer progression.Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells Methylome sequencing for fibrolamellar hepatocellular carcinoma depicts distinctive features.Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.Novel Anti-CRR9/CLPTM1L Antibodies with Antitumorigenic Activity Inhibit Cell Surface Accumulation, PI3K Interaction, and Survival Signaling.A genomic case study of mixed fibrolamellar hepatocellular carcinoma Germline genetics of cancer of unknown primary (CUP) and its specific subtypes Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma.Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.The Potential Role of Krüppel-Like Zinc-Finger Protein Glis3 in Genetic Diseases and Cancers.Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.

P2860

Q28072292-725512E6-C923-4E5E-B25E-349A1E6A907B Q33652971-3EA0A691-30D0-4AB8-A8AA-2324385B0C1F Q34505964-E9534E0E-FA2D-4F08-9612-FAD04199185A Q35062811-26E4B302-8122-4BF2-96C4-2EE2B7CC2D8D Q35742404-7C7C0484-E2F7-4C52-AA9F-AE32A800CD6C Q36000994-CB9558C1-41AE-48B8-B088-14B4F2F86816 Q36145871-EEBD4AA6-83F4-4194-BE9B-1410EF5C546F Q36212867-CC830F66-11CD-4AE8-BF45-49E4A756AB0B Q36268536-9E1D19E7-3DDE-4BB5-B48E-6ADD187660EC Q36918144-F7628A32-C222-4B46-816B-D1507B3DC372 Q36935210-D9FD10DC-AC1A-4414-8BC3-60A9FDF693CD Q37225491-72E37FE1-AE66-42EF-9C68-1EE8BBBAD4CC Q37408965-A2D5BDB6-EAEB-4165-8494-B1F217EFD347 Q38730342-DD66D16B-B5E4-4504-AF75-F34B6C926CF0 Q38901483-97D431FB-8AEC-4E3D-9F6F-BEBAE840C06C Q39317282-51E205BD-C1FD-4FB6-B7E4-B1E261EB9CB2 Q39889043-1088F045-4F3D-420D-A75C-354C18EE2E25 Q40212889-0DB43FE3-F78A-4582-AE69-AC1174462DED Q41670848-038882C6-12E1-4E93-BC0F-C98BCCC91AA8 Q47635386-E929AFFE-0750-4901-A1BF-0AF442E51620 Q52689575-E299EF02-F456-4CD1-90EF-3CC0C7A58AA0 Q54237690-7F1F68BF-49F1-4685-A6CF-4ED6CB611DA7

P2860

Genomic analysis of fibrolamellar hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34673400

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@ast

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@en

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@nl

type

label

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@ast

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@en

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@nl

prefLabel

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@ast

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@en

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@nl

P1433

Q34673400-C60F15D9-41A0-4DFD-90AF-5263487CEABC

P1476

Q34673400-B4CEB348-BAD9-4E25-8A9F-5DE687DB8A69

P2093

Q34673400-06D8E3D4-7915-4822-933C-DC35BDA9D186

Q34673400-24E4CF3C-D579-4464-8C3C-6DF28AE9A922

Q34673400-29C4F762-7636-4FA6-B93E-E7BFE21524D3

Q34673400-3726B041-65D2-45C4-BF3E-A4DF1D9D558F

Q34673400-94788048-0AB8-457B-855E-38532A6287FD

Q34673400-986EA975-6DBF-460C-8F68-C9D80951BC01

Q34673400-AC32A1B3-0E16-4F7F-8E4B-816A381F9487

Q34673400-FF46CDD5-72BB-461A-B1F2-7249D23E3386

P2860

Q34673400-020EBE6B-9679-4F9C-8ABE-718F93E85F85

Q34673400-028BAA94-A3DA-4679-A0AC-03E9802614AB

Q34673400-030E764D-35C1-420E-8974-9DF780EE85C8

Q34673400-03EC517C-51D9-472D-9AD9-41539B07FC54

Q34673400-0EEDDC6C-084B-44BF-B0A0-84F759E3EA2A

Q34673400-1E8E4AEE-3B81-4307-861C-21A7A42C791A

Q34673400-1FCC4018-79C4-44E4-AAE5-629615BB8F3F

Q34673400-2044BA8D-E6F9-464C-AADD-70704ABA1D76

Q34673400-266009E0-CC8B-4005-817A-477421608991

Q34673400-2FA8327A-AC77-4935-ABB7-F5527C35DCA4

P304

Q34673400-06947F0D-916B-4887-8AD7-DE684E06C94E

P31

Q34673400-FC966FA6-9362-455C-9D60-7E22DCD36C75

P356

Q34673400-1C21CB21-786C-4054-AB1B-2BE60CD6099D

P433

Q34673400-22E87510-1550-46F0-AC71-B839EC3FE8AF

P478

Q34673400-A9107AA0-BA2B-466C-96D8-A790347B0E47

P50

Q34673400-2B490FC3-26C8-470B-99C1-15B5E08817E5

P577

Q34673400-1FF49B27-F30C-4694-8065-B5B770403C39

P698

Q34673400-E19D39FE-C9AE-4104-A640-A05FECC4FA8F

P921

Q34673400-68B16F03-2F84-4A64-BB90-60DFF5707B1B

P932

Q34673400-6B929849-FEC8-444D-BDB0-9842B4AEDDEB

P356

P1433

Human Molecular Genetics

P1476

Genomic analysis of fibrolamellar hepatocellular carcinoma.

@en

P2093

Anne-Flore Zmoos

http://www.w3.org/2001/XMLSchema#string

Arun Rangaswami

http://www.w3.org/2001/XMLSchema#string

Florette K Hazard

http://www.w3.org/2001/XMLSchema#string

Hassan Chaib

http://www.w3.org/2001/XMLSchema#string

Lei Xu

http://www.w3.org/2001/XMLSchema#string

Michael P Snyder

http://www.w3.org/2001/XMLSchema#string

Nadine Jahchan

http://www.w3.org/2001/XMLSchema#string

Phillip M Garfin

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia

Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma.

Intracellular localization and partial amino acid sequence of a stress-inducible 40-kDa protein in HeLa cells

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG

Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations

Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

p21-Activated kinase 4 promotes prostate cancer progression through CREB

Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers

P304

50-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDU418

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25122662

http://www.w3.org/2001/XMLSchema#string

P921

Fibrolamellar hepatocellular carcinoma

P932

4262492

http://www.w3.org/2001/XMLSchema#string